Andrea R. GenazzaniPresident, International Society of Gynecological EndocrinologyLourdes IbáñezEndocrinology, Pediatric Research Institute, Sant Joan de Déu Children's Hospital, Barcelona, SpainAndrzej Milewicz Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland.Duru ShahDirector, Department of Gynaecology, Gynaecworld - The Centre for Women's Health and Fertility; Founder President, The PCOS Society (India), Mumbai, Maharashtra, India

• Chapter 1. Early Origins, Diagnosis & Treatment of Adolescent PCOS.- Chapter 2. Early Origins, Diagnosis & Treatment of PCOS in Adolescent Girls.- Chapter 3. Environment factors responsible for obesity and insuline resistance in polycystic ovary syndrome.- Chapter 4. Pathogenesis of PCOS: from metabolic and neuroendocrine implications to the choice of the therapeutic strategy.- Chapter 5. Personalized therapies: why, when and for how long, the need of tailoring.- Chapter 6. Endocrine and molecular features involved in follicular arrest of PCOS women.- Chapter 7. Quality of life and Sexual Health.- Chapter 8. Infertility Management in Lean v/s obese PCOS.- Chapter 9. Treatment of Infertility in women with PCOS.- Chapter 10. Management of PCOS  women preparing pregnancy.- Chapter 11. Impact of polycystic ovarian syndrome, metabolic syndrome and obesity on women’s health.- Chapter 12. Pregnancy outcome and metabolic syndrome.- Chapter 13. PCO and pregnancy: what the physician(or obstetrician) has to know to assure the best pregnancy follow-up.- Chapter 14. The role of insulin resistance in benign breast disease.- Chapter 15. Inflammation and the metabolic syndrome during the menopausal transition.- Chapter 16. Metabolic changes at the menopausal transition.- Chaer 17. Cardiovascular impact  - Cardiovascular impact of metabolic abnormalities.- Chapter 18. How to prevent, to diagnose and to treat gynecological cancer in PCO patients?.

Andrea R. GenazzaniPresident, International Society of Gynecological EndocrinologyLourdes IbáñezEndocrinology, Pediatric Research Institute, Sant Joan de Déu Children's Hospital, Barcelona, SpainAndrzej Milewicz Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland.Duru ShahDirector, Department of Gynaecology, Gynaecworld - The Centre for Women's Health and Fertility; Founder President, The PCOS Society (India), Mumbai, Maharashtra, India

• Chapter 1. Early Origins, Diagnosis & Treatment of Adolescent PCOS.- Chapter 2. Early Origins, Diagnosis & Treatment of PCOS in Adolescent Girls.- Chapter 3. Environment factors responsible for obesity and insuline resistance in polycystic ovary syndrome.- Chapter 4. Pathogenesis of PCOS: from metabolic and neuroendocrine implications to the choice of the therapeutic strategy.- Chapter 5. Personalized therapies: why, when and for how long, the need of tailoring.- Chapter 6. Endocrine and molecular features involved in follicular arrest of PCOS women.- Chapter 7. Quality of life and Sexual Health.- Chapter 8. Infertility Management in Lean v/s obese PCOS.- Chapter 9. Treatment of Infertility in women with PCOS.- Chapter 10. Management of PCOS  women preparing pregnancy.- Chapter 11. Impact of polycystic ovarian syndrome, metabolic syndrome and obesity on women’s health.- Chapter 12. Pregnancy outcome and metabolic syndrome.- Chapter 13. PCO and pregnancy: what the physician(or obstetrician) has to know to assure the best pregnancy follow-up.- Chapter 14. The role of insulin resistance in benign breast disease.- Chapter 15. Inflammation and the metabolic syndrome during the menopausal transition.- Chapter 16. Metabolic changes at the menopausal transition.- Chaer 17. Cardiovascular impact  - Cardiovascular impact of metabolic abnormalities.- Chapter 18. How to prevent, to diagnose and to treat gynecological cancer in PCO patients?.

Andrea R. GenazzaniPresident, International Society of Gynecological EndocrinologyLourdes IbáñezEndocrinology, Pediatric Research Institute, Sant Joan de Déu Children's Hospital, Barcelona, SpainAndrzej Milewicz Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland.Duru ShahDirector, Department of Gynaecology, Gynaecworld - The Centre for Women's Health and Fertility; Founder President, The PCOS Society (India), Mumbai, Maharashtra, India

• Chapter 1. Early Origins, Diagnosis & Treatment of Adolescent PCOS.- Chapter 2. Early Origins, Diagnosis & Treatment of PCOS in Adolescent Girls.- Chapter 3. Environment factors responsible for obesity and insuline resistance in polycystic ovary syndrome.- Chapter 4. Pathogenesis of PCOS: from metabolic and neuroendocrine implications to the choice of the therapeutic strategy.- Chapter 5. Personalized therapies: why, when and for how long, the need of tailoring.- Chapter 6. Endocrine and molecular features involved in follicular arrest of PCOS women.- Chapter 7. Quality of life and Sexual Health.- Chapter 8. Infertility Management in Lean v/s obese PCOS.- Chapter 9. Treatment of Infertility in women with PCOS.- Chapter 10. Management of PCOS  women preparing pregnancy.- Chapter 11. Impact of polycystic ovarian syndrome, metabolic syndrome and obesity on women’s health.- Chapter 12. Pregnancy outcome and metabolic syndrome.- Chapter 13. PCO and pregnancy: what the physician(or obstetrician) has to know to assure the best pregnancy follow-up.- Chapter 14. The role of insulin resistance in benign breast disease.- Chapter 15. Inflammation and the metabolic syndrome during the menopausal transition.- Chapter 16. Metabolic changes at the menopausal transition.- Chaer 17. Cardiovascular impact  - Cardiovascular impact of metabolic abnormalities.- Chapter 18. How to prevent, to diagnose and to treat gynecological cancer in PCO patients?.